The U.S. market for cardiovascular disease diagnostic products is expected to exceed $3.9 billion in 2004, growing to over $4.7 billion in 2007. Drivers of this growth include imaging systems as well as near-patient in vitro diagnostic testing products, with both segments increasing at double-digit rates through 2007, according to a report issued by market research firm Medtech Insight
The report, U.S. Markets for Cardiovascular Disease Diagnostic Products, includes analyses of technologies, market forecasts, competitors, and opportunities in electrocardiography, conventional x-ray-based imaging, CT, MRI, nuclear medicine, and ultrasound imaging systems.
The report also covers x-ray and CT contrast media, nuclear medicine radiopharmaceuticals and ultrasound contrast agents, angiography devices, intravascular ultrasound systems, functional angiometry products, diagnostic electrophysiology catheters, and cardiac marker, cholesterol/lipid testing, and coagulation testing systems, according to the Newport Beach, CA-based firm.
By AuntMinnie.com staff writersMay 27, 2004
Related Reading
Oncology imaging market predicted to grow 8.2% annually, October 7, 2003
Breast-detection market to grow 17% in 2002, November 14, 2002
Copyright © 2004 AuntMinnie.com
